Insider Trades21 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Sell | PLRX | Minnie Kuo | Chief Operating Officer | 6,917 | $1.28 | $72.4M | -40.00% | +14.71% | $8.9K | -15.47% | — | — |
| Jan 20, 2026 | Sell | PLRX | Lily Cheung | Chief Human Resource Officer | 7,534 | $1.28 | $72.4M | -40.00% | +14.71% | $9.6K | -14.38% | — | — |
| Jan 20, 2026 | Sell | PLRX | Keith Lamont Cummings | Chief Financial Officer | 24,002 | $1.28 | $72.4M | -40.00% | +14.71% | $30.7K | -7.47% | — | — |
| Jan 20, 2026 | Sell | PLRX | Bernard Coulie | President and CEO | 89,375 | $1.28 | $72.4M | -40.00% | +14.71% | $114.4K | -15.02% | — | — |
| Jan 17, 2025 | Sell | PLRX | Lily Cheung | Chief Human Resource Officer | 3,740 | $11.20 | $72.4M | -40.00% | +14.71% | $41.9K | -13.22% | — | — |
| Jan 17, 2025 | Sell | PLRX | Hans Hull | Chief Business Officer | 15,936 | $11.20 | $72.4M | -40.00% | +14.71% | $178.5K | -7.01% | — | — |
| Jan 17, 2025 | Sell | PLRX | Eric Lefebvre | Chief Medical Officer | 18,478 | $11.20 | $72.4M | -40.00% | +14.71% | $207.0K | -8.67% | — | — |
| Jan 17, 2025 | Sell | PLRX | Keith Lamont Cummings | Chief Financial Officer | 20,148 | $11.20 | $72.4M | -40.00% | +14.71% | $225.7K | -7.13% | — | — |
| Jan 17, 2025 | Sell | PLRX | Mike Ouimette | General Counsel & Corp. Sec'y | 23,500 | $11.11 | $72.4M | -40.00% | +14.71% | $261.1K | -13.44% | 10b5-1 | — |
| Jan 17, 2025 | Sell | PLRX | Bernard Coulie | President and CEO | 52,419 | $11.20 | $72.4M | -40.00% | +14.71% | $587.2K | -10.85% | — | — |
| Jul 10, 2024 | Sell | PLRX | Mike Ouimette | General Counsel & Corp. Sec'y | 7,656 | $11.56 | $72.4M | -40.00% | +14.71% | $88.5K | -7.53% | — | — |
| Jul 10, 2024 | Sell | PLRX | Hans Hull | Chief Business Officer | 9,900 | $11.56 | $72.4M | -40.00% | +14.71% | $114.4K | -4.17% | — | — |
| Jul 10, 2024 | Sell | PLRX | Keith Lamont Cummings | Chief Financial Officer | 10,911 | $11.56 | $72.4M | -40.00% | +14.71% | $126.1K | -3.72% | — | — |
| Jul 10, 2024 | Sell | PLRX | Eric Lefebvre | Chief Medical Officer | 12,319 | $11.56 | $72.4M | -40.00% | +14.71% | $142.4K | -5.47% | — | — |
| Jul 10, 2024 | Sell | PLRX | Bernard Coulie | President and CEO | 38,710 | $11.56 | $72.4M | -40.00% | +14.71% | $447.5K | -7.42% | — | — |
| May 2, 2024 | Buy | PLRX | Keith Lamont Cummings | Chief Financial Officer | 21,000 | $2.08 | $72.4M | -40.00% | +14.71% | $43.7K | +6.43% | — | — |
| Jan 17, 2024 | Sell | PLRX | Mike Ouimette | General Counsel & Corp. Sec'y | 5,197 | $17.23 | $72.4M | -40.00% | +14.71% | $89.5K | -8.60% | — | — |
| Jan 17, 2024 | Sell | PLRX | Keith Lamont Cummings | Chief Financial Officer | 9,781 | $17.23 | $72.4M | -40.00% | +14.71% | $168.5K | -4.79% | — | — |
| Jan 17, 2024 | Sell | PLRX | Hans Hull | Chief Business Officer | 9,786 | $17.23 | $72.4M | -40.00% | +14.71% | $168.6K | -5.02% | — | — |
| Jan 17, 2024 | Sell | PLRX | Eric Lefebvre | Chief Medical Officer | 10,295 | $17.23 | $72.4M | -40.00% | +14.71% | $177.4K | -6.16% | — | — |
| Jan 17, 2024 | Sell | PLRX | Bernard Coulie | President and CEO | 25,721 | $17.23 | $72.4M | -40.00% | +14.71% | $443.2K | -7.52% | — | — |